The global Nuclear Radiopharmaceutical market was valued at US$ 6124 million in 2023 and is anticipated to reach US$ 10180 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.

Nuclear Radiopharmaceutical Market

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Radiopharmaceutical.

The Nuclear Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Nuclear Radiopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Radiopharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Radiopharmaceutical Market Report

Report Metric	Details
Report Name	Nuclear Radiopharmaceutical Market
Accounted market size in 2023	US$ 6124 million
Forecasted market size in 2030	US$ 10180 million
CAGR	7.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Diagnostic Radiopharmaceuticals Therapeutic Radiopharmaceuticals
Segment by Application	Oncology Thyroid Cardiology Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Radiopharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nuclear Radiopharmaceutical Market growing?

Ans: The Nuclear Radiopharmaceutical Market witnessing a CAGR of 7.3% during the forecast period 2024-2030.

What is the Nuclear Radiopharmaceutical Market size in 2030?

Ans: The Nuclear Radiopharmaceutical Market size in 2030 will be US$ 10180 million.

Who are the main players in the Nuclear Radiopharmaceutical Market report?

Ans: The main players in the Nuclear Radiopharmaceutical Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the Nuclear Radiopharmaceutical Market report?

Ans: The Applications covered in the Nuclear Radiopharmaceutical Market report are Oncology, Thyroid, Cardiology, Others

What are the Type segmentation covered in the Nuclear Radiopharmaceutical Market report?

Ans: The Types covered in the Nuclear Radiopharmaceutical Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

1 Nuclear Radiopharmaceutical Market Overview

1.1 Product Definition

1.2 Nuclear Radiopharmaceutical by Type

1.2.1 Global Nuclear Radiopharmaceutical Market Value Comparison by Type (2024-2030)

1.2.2 Diagnostic Radiopharmaceuticals

1.2.3 Therapeutic Radiopharmaceuticals

1.3 Nuclear Radiopharmaceutical by Application

1.3.1 Global Nuclear Radiopharmaceutical Market Value by Application (2024-2030)

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Global Nuclear Radiopharmaceutical Market Size Estimates and Forecasts

1.4.1 Global Nuclear Radiopharmaceutical Revenue 2019-2030

1.4.2 Global Nuclear Radiopharmaceutical Sales 2019-2030

1.4.3 Global Nuclear Radiopharmaceutical Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Nuclear Radiopharmaceutical Market Competition by Manufacturers

2.1 Global Nuclear Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)

2.2 Global Nuclear Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Nuclear Radiopharmaceutical Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Nuclear Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Type & Application

2.7 Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry

2.8 Global Nuclear Radiopharmaceutical Market Competitive Situation and Trends

2.8.1 Global Nuclear Radiopharmaceutical Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nuclear Radiopharmaceutical Players Market Share by Revenue

2.8.3 Global Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nuclear Radiopharmaceutical Market Scenario by Region

3.1 Global Nuclear Radiopharmaceutical Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Nuclear Radiopharmaceutical Sales by Region: 2019-2030

3.2.1 Global Nuclear Radiopharmaceutical Sales by Region: 2019-2024

3.2.2 Global Nuclear Radiopharmaceutical Sales by Region: 2025-2030

3.3 Global Nuclear Radiopharmaceutical Revenue by Region: 2019-2030

3.3.1 Global Nuclear Radiopharmaceutical Revenue by Region: 2019-2024

3.3.2 Global Nuclear Radiopharmaceutical Revenue by Region: 2025-2030

3.4 North America Nuclear Radiopharmaceutical Market Facts & Figures by Country

3.4.1 North America Nuclear Radiopharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Nuclear Radiopharmaceutical Sales by Country (2019-2030)

3.4.3 North America Nuclear Radiopharmaceutical Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nuclear Radiopharmaceutical Market Facts & Figures by Country

3.5.1 Europe Nuclear Radiopharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Nuclear Radiopharmaceutical Sales by Country (2019-2030)

3.5.3 Europe Nuclear Radiopharmaceutical Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nuclear Radiopharmaceutical Market Facts & Figures by Region

3.6.1 Asia Pacific Nuclear Radiopharmaceutical Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Nuclear Radiopharmaceutical Sales by Region (2019-2030)

3.6.3 Asia Pacific Nuclear Radiopharmaceutical Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Nuclear Radiopharmaceutical Market Facts & Figures by Country

3.7.1 Latin America Nuclear Radiopharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Nuclear Radiopharmaceutical Sales by Country (2019-2030)

3.7.3 Latin America Nuclear Radiopharmaceutical Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nuclear Radiopharmaceutical Market Facts & Figures by Country

3.8.1 Middle East and Africa Nuclear Radiopharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Nuclear Radiopharmaceutical Sales by Country (2019-2030)

3.8.3 Middle East and Africa Nuclear Radiopharmaceutical Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nuclear Radiopharmaceutical Sales by Type (2019-2030)

4.1.1 Global Nuclear Radiopharmaceutical Sales by Type (2019-2024)

4.1.2 Global Nuclear Radiopharmaceutical Sales by Type (2025-2030)

4.1.3 Global Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)

4.2 Global Nuclear Radiopharmaceutical Revenue by Type (2019-2030)

4.2.1 Global Nuclear Radiopharmaceutical Revenue by Type (2019-2024)

4.2.2 Global Nuclear Radiopharmaceutical Revenue by Type (2025-2030)

4.2.3 Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)

4.3 Global Nuclear Radiopharmaceutical Price by Type (2019-2030)

5 Segment by Application

5.1 Global Nuclear Radiopharmaceutical Sales by Application (2019-2030)

5.1.1 Global Nuclear Radiopharmaceutical Sales by Application (2019-2024)

5.1.2 Global Nuclear Radiopharmaceutical Sales by Application (2025-2030)

5.1.3 Global Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)

5.2 Global Nuclear Radiopharmaceutical Revenue by Application (2019-2030)

5.2.1 Global Nuclear Radiopharmaceutical Revenue by Application (2019-2024)

5.2.2 Global Nuclear Radiopharmaceutical Revenue by Application (2025-2030)

5.2.3 Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)

5.3 Global Nuclear Radiopharmaceutical Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Cardinal Health

6.1.1 Cardinal Health Company Information

6.1.2 Cardinal Health Description and Business Overview

6.1.3 Cardinal Health Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Cardinal Health Nuclear Radiopharmaceutical Product Portfolio

6.1.5 Cardinal Health Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Company Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GE Healthcare Nuclear Radiopharmaceutical Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Jubilant Pharma

6.3.1 Jubilant Pharma Company Information

6.3.2 Jubilant Pharma Description and Business Overview

6.3.3 Jubilant Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Jubilant Pharma Nuclear Radiopharmaceutical Product Portfolio

6.3.5 Jubilant Pharma Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Company Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Nuclear Radiopharmaceutical Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Curium Pharma

6.5.1 Curium Pharma Company Information

6.5.2 Curium Pharma Description and Business Overview

6.5.3 Curium Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Curium Pharma Nuclear Radiopharmaceutical Product Portfolio

6.5.5 Curium Pharma Recent Developments/Updates

6.6 SIEMENS

6.6.1 SIEMENS Company Information

6.6.2 SIEMENS Description and Business Overview

6.6.3 SIEMENS Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.6.4 SIEMENS Nuclear Radiopharmaceutical Product Portfolio

6.6.5 SIEMENS Recent Developments/Updates

6.7 Lantheus

6.7.1 Lantheus Company Information

6.7.2 Lantheus Description and Business Overview

6.7.3 Lantheus Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Lantheus Nuclear Radiopharmaceutical Product Portfolio

6.7.5 Lantheus Recent Developments/Updates

6.8 Bracco Imaging

6.8.1 Bracco Imaging Company Information

6.8.2 Bracco Imaging Description and Business Overview

6.8.3 Bracco Imaging Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bracco Imaging Nuclear Radiopharmaceutical Product Portfolio

6.8.5 Bracco Imaging Recent Developments/Updates

6.9 Bayer

6.9.1 Bayer Company Information

6.9.2 Bayer Description and Business Overview

6.9.3 Bayer Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Bayer Nuclear Radiopharmaceutical Product Portfolio

6.9.5 Bayer Recent Developments/Updates

6.10 Eli Lilly

6.10.1 Eli Lilly Company Information

6.10.2 Eli Lilly Description and Business Overview

6.10.3 Eli Lilly Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Eli Lilly Nuclear Radiopharmaceutical Product Portfolio

6.10.5 Eli Lilly Recent Developments/Updates

6.11 Aurobindo Pharma

6.11.1 Aurobindo Pharma Company Information

6.11.2 Aurobindo Pharma Description and Business Overview

6.11.3 Aurobindo Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Aurobindo Pharma Nuclear Radiopharmaceutical Product Portfolio

6.11.5 Aurobindo Pharma Recent Developments/Updates

6.12 Mundipharma

6.12.1 Mundipharma Company Information

6.12.2 Mundipharma Description and Business Overview

6.12.3 Mundipharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Mundipharma Nuclear Radiopharmaceutical Product Portfolio

6.12.5 Mundipharma Recent Developments/Updates

6.13 China Isotope & Radiation

6.13.1 China Isotope & Radiation Company Information

6.13.2 China Isotope & Radiation Description and Business Overview

6.13.3 China Isotope & Radiation Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.13.4 China Isotope & Radiation Nuclear Radiopharmaceutical Product Portfolio

6.13.5 China Isotope & Radiation Recent Developments/Updates

6.14 Dongcheng

6.14.1 Dongcheng Company Information

6.14.2 Dongcheng Description and Business Overview

6.14.3 Dongcheng Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Dongcheng Nuclear Radiopharmaceutical Product Portfolio

6.14.5 Dongcheng Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nuclear Radiopharmaceutical Industry Chain Analysis

7.2 Nuclear Radiopharmaceutical Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nuclear Radiopharmaceutical Production Mode & Process

7.4 Nuclear Radiopharmaceutical Sales and Marketing

7.4.1 Nuclear Radiopharmaceutical Sales Channels

7.4.2 Nuclear Radiopharmaceutical Distributors

7.5 Nuclear Radiopharmaceutical Customers

8 Nuclear Radiopharmaceutical Market Dynamics

8.1 Nuclear Radiopharmaceutical Industry Trends

8.2 Nuclear Radiopharmaceutical Market Drivers

8.3 Nuclear Radiopharmaceutical Market Challenges

8.4 Nuclear Radiopharmaceutical Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Curium Pharma

Cardinal Health

GE Healthcare

China Isotope & Radiation

List of Tables

Table 1. Global Nuclear Radiopharmaceutical Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Nuclear Radiopharmaceutical Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Nuclear Radiopharmaceutical Market Competitive Situation by Manufacturers in 2023

Table 4. Global Nuclear Radiopharmaceutical Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Nuclear Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Nuclear Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Nuclear Radiopharmaceutical Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Nuclear Radiopharmaceutical Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Nuclear Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Type & Application

Table 12. Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nuclear Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nuclear Radiopharmaceutical Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (K Units)

Table 18. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2024)

Table 19. Global Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (K Units)

Table 20. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2025-2030)

Table 21. Global Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2024)

Table 23. Global Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2025-2030)

Table 25. North America Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (K Units)

Table 27. North America Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (K Units)

Table 28. North America Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (K Units)

Table 32. Europe Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (K Units)

Table 33. Europe Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Nuclear Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Nuclear Radiopharmaceutical Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Nuclear Radiopharmaceutical Sales (K Units) by Type (2019-2024)

Table 51. Global Nuclear Radiopharmaceutical Sales (K Units) by Type (2025-2030)

Table 52. Global Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2024)

Table 53. Global Nuclear Radiopharmaceutical Sales Market Share by Type (2025-2030)

Table 54. Global Nuclear Radiopharmaceutical Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Nuclear Radiopharmaceutical Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2024)

Table 57. Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2025-2030)

Table 58. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Type (2019-2024)

Table 59. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Type (2025-2030)

Table 60. Global Nuclear Radiopharmaceutical Sales (K Units) by Application (2019-2024)

Table 61. Global Nuclear Radiopharmaceutical Sales (K Units) by Application (2025-2030)

Table 62. Global Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2024)

Table 63. Global Nuclear Radiopharmaceutical Sales Market Share by Application (2025-2030)

Table 64. Global Nuclear Radiopharmaceutical Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Nuclear Radiopharmaceutical Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2024)

Table 67. Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2025-2030)

Table 68. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Application (2019-2024)

Table 69. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Application (2025-2030)

Table 70. Cardinal Health Company Information

Table 71. Cardinal Health Description and Business Overview

Table 72. Cardinal Health Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Cardinal Health Nuclear Radiopharmaceutical Product

Table 74. Cardinal Health Recent Developments/Updates

Table 75. GE Healthcare Company Information

Table 76. GE Healthcare Description and Business Overview

Table 77. GE Healthcare Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GE Healthcare Nuclear Radiopharmaceutical Product

Table 79. GE Healthcare Recent Developments/Updates

Table 80. Jubilant Pharma Company Information

Table 81. Jubilant Pharma Description and Business Overview

Table 82. Jubilant Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Jubilant Pharma Nuclear Radiopharmaceutical Product

Table 84. Jubilant Pharma Recent Developments/Updates

Table 85. Novartis Company Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis Nuclear Radiopharmaceutical Product

Table 89. Novartis Recent Developments/Updates

Table 90. Curium Pharma Company Information

Table 91. Curium Pharma Description and Business Overview

Table 92. Curium Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Curium Pharma Nuclear Radiopharmaceutical Product

Table 94. Curium Pharma Recent Developments/Updates

Table 95. SIEMENS Company Information

Table 96. SIEMENS Description and Business Overview

Table 97. SIEMENS Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. SIEMENS Nuclear Radiopharmaceutical Product

Table 99. SIEMENS Recent Developments/Updates

Table 100. Lantheus Company Information

Table 101. Lantheus Description and Business Overview

Table 102. Lantheus Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Lantheus Nuclear Radiopharmaceutical Product

Table 104. Lantheus Recent Developments/Updates

Table 105. Bracco Imaging Company Information

Table 106. Bracco Imaging Description and Business Overview

Table 107. Bracco Imaging Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Bracco Imaging Nuclear Radiopharmaceutical Product

Table 109. Bracco Imaging Recent Developments/Updates

Table 110. Bayer Company Information

Table 111. Bayer Description and Business Overview

Table 112. Bayer Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Bayer Nuclear Radiopharmaceutical Product

Table 114. Bayer Recent Developments/Updates

Table 115. Eli Lilly Company Information

Table 116. Eli Lilly Description and Business Overview

Table 117. Eli Lilly Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Eli Lilly Nuclear Radiopharmaceutical Product

Table 119. Eli Lilly Recent Developments/Updates

Table 120. Aurobindo Pharma Company Information

Table 121. Aurobindo Pharma Description and Business Overview

Table 122. Aurobindo Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Aurobindo Pharma Nuclear Radiopharmaceutical Product

Table 124. Aurobindo Pharma Recent Developments/Updates

Table 125. Mundipharma Company Information

Table 126. Mundipharma Description and Business Overview

Table 127. Mundipharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Mundipharma Nuclear Radiopharmaceutical Product

Table 129. Mundipharma Recent Developments/Updates

Table 130. China Isotope & Radiation Company Information

Table 131. China Isotope & Radiation Description and Business Overview

Table 132. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. China Isotope & Radiation Nuclear Radiopharmaceutical Product

Table 134. China Isotope & Radiation Recent Developments/Updates

Table 135. Dongcheng Company Information

Table 136. Dongcheng Description and Business Overview

Table 137. Dongcheng Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Dongcheng Nuclear Radiopharmaceutical Product

Table 139. Dongcheng Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Nuclear Radiopharmaceutical Distributors List

Table 143. Nuclear Radiopharmaceutical Customers List

Table 144. Nuclear Radiopharmaceutical Market Trends

Table 145. Nuclear Radiopharmaceutical Market Drivers

Table 146. Nuclear Radiopharmaceutical Market Challenges

Table 147. Nuclear Radiopharmaceutical Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nuclear Radiopharmaceutical

Figure 2. Global Nuclear Radiopharmaceutical Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Nuclear Radiopharmaceutical Market Share by Type: 2023 & 2030

Figure 4. Diagnostic Radiopharmaceuticals Product Picture

Figure 5. Therapeutic Radiopharmaceuticals Product Picture

Figure 6. Global Nuclear Radiopharmaceutical Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Nuclear Radiopharmaceutical Market Share by Application: 2023 & 2030

Figure 8. Oncology

Figure 9. Thyroid

Figure 10. Cardiology

Figure 11. Others

Figure 12. Global Nuclear Radiopharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Nuclear Radiopharmaceutical Market Size (2019-2030) & (US$ Million)

Figure 14. Global Nuclear Radiopharmaceutical Sales (2019-2030) & (K Units)

Figure 15. Global Nuclear Radiopharmaceutical Average Price (US$/Unit) & (2019-2030)

Figure 16. Nuclear Radiopharmaceutical Report Years Considered

Figure 17. Nuclear Radiopharmaceutical Sales Share by Manufacturers in 2023

Figure 18. Global Nuclear Radiopharmaceutical Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Nuclear Radiopharmaceutical Players: Market Share by Revenue in Nuclear Radiopharmaceutical in 2023

Figure 20. Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Nuclear Radiopharmaceutical Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Nuclear Radiopharmaceutical Sales Market Share by Country (2019-2030)

Figure 23. North America Nuclear Radiopharmaceutical Revenue Market Share by Country (2019-2030)

Figure 24. United States Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Nuclear Radiopharmaceutical Sales Market Share by Country (2019-2030)

Figure 27. Europe Nuclear Radiopharmaceutical Revenue Market Share by Country (2019-2030)

Figure 28. Germany Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2030)

Figure 35. China Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Nuclear Radiopharmaceutical Sales Market Share by Country (2019-2030)

Figure 43. Mexico Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Nuclear Radiopharmaceutical Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Nuclear Radiopharmaceutical Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Nuclear Radiopharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Nuclear Radiopharmaceutical by Type (2019-2030)

Figure 52. Global Revenue Market Share of Nuclear Radiopharmaceutical by Type (2019-2030)

Figure 53. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Nuclear Radiopharmaceutical by Application (2019-2030)

Figure 55. Global Revenue Market Share of Nuclear Radiopharmaceutical by Application (2019-2030)

Figure 56. Global Nuclear Radiopharmaceutical Price (US$/Unit) by Application (2019-2030)

Figure 57. Nuclear Radiopharmaceutical Value Chain

Figure 58. Nuclear Radiopharmaceutical Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31V13609

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Medipower - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-16Y13193

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Medical Towel Sterilizer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37X13776

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Ventilators and Oxygen Concentrators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34B12827

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Nuclear Radiopharmaceutical Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-26K13655

Global Nuclear Radiopharmaceutical Market Research Report 2024

FEATURED COMPANIES

Nuclear Radiopharmaceutical Market Size

Nuclear Radiopharmaceutical Market

Report Scope

Scope of Nuclear Radiopharmaceutical Market Report

Core Chapters

FAQ for this report

How fast is Nuclear Radiopharmaceutical Market growing?

What is the Nuclear Radiopharmaceutical Market size in 2030?

Who are the main players in the Nuclear Radiopharmaceutical Market report?

What are the Application segmentation covered in the Nuclear Radiopharmaceutical Market report?

What are the Type segmentation covered in the Nuclear Radiopharmaceutical Market report?

FEATURED COMPANIES

RELATED REPORTS